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Relationship of hemodialysis access to finger
gangrene in patients with end-stage renal disease
Richard A. Yeager, MD, Gregory L. Moneta, MD, James M. Edwards, MD, Gregory J. Landry, MD,
Lloyd M. Taylor, Jr, MD, Donald B. McConnell, MD, and John M. Porter, MD, Portland, Ore
Objective: We report a comprehensive review of our patients on hemodialysis with end-stage renal disease (ESRD) with
finger gangrene to determine etiology, natural history, and prognosis of this condition.
Methods: Patients with ESRD with finger gangrene were identified from our computerized vascular registry. Presence of
an ipsilateral arteriovenous fistula was determined, and patients were compared with a group of patients with ESRD
without finger gangrene. Management consisted of arteriography, selective arteriovenous fistula management, and finger
amputation. A multivariate analysis to determine risk factors associated with finger gangrene was performed. Repeat
finger amputation and survival rates were determined with life-table analysis.
Results: Twenty-three patients (mean age at start of dialysis, 53 years) with finger gangrene were identified, with 48%
(n  11) having a functional ipsilateral arteriovenous fistula. Arteriography was consistent with diffuse atherosclerosis
involving the radial, ulnar, palmar, and digital arteries precluding attempts at distal arterial bypass. Repeat finger
amputations were necessitated in 52% of patients (n 12), and bilateral finger gangrene developed in 61% of patients (n
14). Starting dialysis at age less than 55 years (P .0004), diabetes (P .001), coronary artery disease (P .0212), and
lower extremity arterial occlusive disease (P < .0001) were significantly associated with finger gangrene.
Conclusion: The young diabetic patient with diffuse vascular disease and ESRD is at high risk for the development of
finger gangrene on chronic hemodialysis. Finger gangrene is the result of distal atherosclerosis and is not primarily related
to dialysis access. (J Vasc Surg 2002;36:245-9.)
Finger gangrene as the result of upper extremity arterial
occlusive disease is a relatively infrequent clinical problem.1
Only a minority of patients in our practice with finger
gangrene have end-stage renal disease (ESRD). Questions
frequently arise as to etiology of finger gangrene in these
patients and relationship of the problem to an upper ex-
tremity hemodialysis access arteriovenous fistula or shunt.
Objectively, little is known about the etiology, natural
history, prognosis, and recommended management for
these challenging cases.
Recent literature addressing the issue of hand ischemia
in patients with ESRD on hemodialysis has been concerned
with the treatment of hemodynamic steal syndrome in-
duced by an arteriovenous shunt or fistula.2,3 However,
patients with ESRD with finger gangrene represent a more
advanced and chronic form of upper extremity ischemia of
which less is known concerning its relationship to a dialysis
arteriovenous fistula or shunt. We are reporting herein a
comprehensive review of our patients with ESRD on he-
modialysis with finger gangrene to determine the etiology
and natural history of this condition.
PATIENTS AND METHODS
All patients with finger gangrene on chronic hemodial-
ysis encountered (from January 1991 through December
2000) on our combined (Veterans Affairs Medical Center
VAMC; University Hospital) vascular service were identi-
fied from a computerized patient registry. Patients with
finger gangrene routinely were assessed for atherosclerotic
risk factors and underwent bilateral upper extremity pho-
toplethysmographic testing and angiography.4 The gan-
grenous fingers could not be assessed with photoplethys-
mographic tracings; however, all other fingers were tested.
Patients with ipsilateral functional upper extremity arterio-
venous fistula underwent testing with and without com-
pression of the fistula. Treatment consisted of digital am-
putation and selective arteriovenous fistula management.
Patients were followed for the need for repeat finger ampu-
tation or hand amputation.
Patients on chronic hemodialysis at the Veterans Affairs
Medical Center who were followed during the study period
without finger gangrene served as a comparison group.
Patients were identified from a database, and records were
reviewed and assessed for the presence of atherosclerotic
risk factors to include age, gender, diabetes, smoking his-
tory, hypertension, hyperlipidemia, lower extremity arterial
occlusive disease (LED), and coronary artery disease
(CAD). LED was defined as absent distal pulses to palpa-
tion or an ankle/brachial Doppler pressure index of less
than 0.90. In addition, all study patients were assessed for
age at initiation of dialysis and survival on dialysis.
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Statistical analysis. Analysis of risk factors in patients
with finger gangrene compared with other study patients
was performed with 2 or Fisher exact tests for conditional
variables and Student t test for continuous variables. A
significant difference was assumed when P was less than .05.
A multivariate analysis (one-way analysis of variance) to
determine risk factors associated with finger gangrene also
was performed. Patients also were assessed for survival,
repeat finger amputation, and requirement for hand ampu-
tation. These results were calculated with the life-table
method. In addition, survival rate from initiation of dialysis
was calculated with the life-table method for patients with
and without gangrene with differences determined with
log-rank and 2 analysis.
RESULTS
During the 10-year study period, 23 patients with
finger gangrene (mean age at initiation of dialysis, 53 years;
range, 30 to 75 years; 20 male, three female) on chronic
hemodialysis underwent management. In addition, 199
patients (mean age at initiation of dialysis, 63 years; range,
23 to 90 years; 195 male, four female) on chronic hemo-
dialysis at the Veterans Affairs Medical Center without
finger gangrene were followed. Patients with finger gan-
grene started dialysis at a significantly (P  .001) younger
age (mean, 53 years) compared with patients without finger
gangrene (mean, 63 years). Mean age at time of finger
gangrene was 57 years. Mean time from the initiation of
dialysis to finger gangrene was 36 months (range, 0 to 205
months).
Finger gangrene presented (14 patients right hand, six
patients left hand, and three patients bilateral) initially
ipsilateral to a dialysis fistula in 11 patients (48%), and in the
other 12 patients (52%), initial finger gangrene presented in
an extremity without a functional dialysis fistula. In five of
these 12 patients, an occluded ipsilateral dialysis fistula had
been nonfunctional for a mean of 21 months (range, 8 to
35 months) before the onset of finger gangrene. In patients
with finger gangrene, the digital photoplethysmographic/
brachial indexes were consistently abnormal with evidence
for bilateral infrabrachial arterial occlusive disease (right
hand: mean, 0.51; range, 0.23 to 0.88; left hand: mean,
0.49; range, 0.21 to 0.92).
Arteriography in all patients showed distal radial or
ulnar disease and severe palmar and digital arterial disease
(Fig 1). No patient had a distal target artery acceptable for
bypass, although two patients underwent proximal brachial
artery bypass and one patient underwent a distal revascu-
larization interval ligation (DRIL) procedure. In six of 11
patients with finger gangrene ipsilateral to a dialysis fistula,
the fistula was either ligated (n  4) or spontaneously
thrombosed (n  2). The remaining five patients with
functional ipsilateral fistula included one patient with a
DRIL procedure, two patients with bilateral gangrene, and
two patients who survived only a few months. In each case,
no significant improvement was seen in measured digital
photoplethysmographic/brachial indexes or angiographic
hand circulation after fistula compression. Alternative
methods for dialysis in the other 18 patients without func-
tional ipsilateral fistula included central vein catheter in 11
patients, peritoneal dialysis in three patients, groin arterio-
venous fistula in two patients, chest wall arteriovenous
fistula in one patient, and contralateral upper extremity
arteriovenous fistula in one patient.
All patients with finger gangrene underwent initial
treatment with distal finger amputation of one or more
digits. During follow-up (mean, 12 months), 14 patients
(61%) had finger gangrene in their previously unaffected
hand and 12 (52%) needed repeat finger amputation, rang-
ing from two to five procedures per patient, totaling one to
Fig 1. Arteriogram shows diffuse atherosclerotic occlusive disease involving radial and ulnar arteries and incomplete
diseased palmar arch and digital arterial occlusions.
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six fingers amputated. No patients needed hand amputa-
tion. At 2 years, the rates of freedom from repeat finger
amputation and hand amputation were 32% and 100%,
respectively (Fig 2). Patient survival rate after the onset of
finger gangrene was 27% at 2 years (Fig 3).
The incidence of atherosclerotic risk factors associated
with finger gangrene in patients on hemodialysis is shown
in the Table. The presence of diabetes, LED, and CAD and
age less than 55 years at the start of dialysis were all
significantly associated with the development of finger gan-
grene while on dialysis. Multivariate analysis was carried out
after excluding LED because of overlap with CAD and
diabetes. With multivariate analysis, CAD (P  .0271),
diabetes (P .0030), and age less than 55 years at the start
of dialysis (P .0001) were all significantly associated with
finger gangrene. The 3-year survival rate on dialysis was
52% in the patients with finger gangrene compared with
49% in the patients without finger gangrene (P  .05; Fig
4).
LED was present in altogether 91 patients studied
(41%), including all 23 patients with finger gangrene and
68 of 199 patients without finger gangrene (34%). LED
was documented before the onset of dialysis in 21 of 23
patients with finger gangrene (91%) and in 57 of the 68
patients in the comparison group (84%). Sixteen of the 23
patients with finger gangrene (70%) needed lower extrem-
ity revascularization compared with 25 of 68 patients in the
comparison group with LED (37%). Of the 41 patients
with LED who underwent lower extremity revasculariza-
tion, 24 patients (59%) needed arterial bypass while on
chronic hemodialysis. Sixteen of the 23 patients with finger
gangrene (70%) underwent at least one major lower ex-
tremity amputation compared with 22 of the 199 patients
in the comparison group ((11%; P  .05).
DISCUSSION
The occurrence of hand ischemia in patients on chronic
hemodialysis is well described. However, most attention by
vascular surgeons has focused on the steal phenomenon
caused by upper extremity arteriovenous fistulas resulting
in the rather abrupt onset of global hand ischemia. The
DRIL procedure has been recommended by several authors
as a method to correct the steal phenomenon and preserve
function of the arteriovenous fistula.2,3 Finger gangrene is a
more advanced form of hand ischemia encountered in the
chronic hemodialysis population, which surprisingly in our
experience was unrelated to a functional arteriovenous
fistula in 52% of cases. However, ipsilateral arteriovenous
fistula was clearly a contributing factor to the problem in at
least five cases, with four shunts necessitating ligation and
one DRIL procedure performed. It is noteworthy that,
during follow-up and after selective fistula management,
altogether 52% of patients returned with new digital gan-
grene necessitating repeat finger amputation procedures
and 61% of patients had bilateral digital gangrene develop.
Uniformly, patients with finger gangrene were found
to have distal atherosclerotic disease not amenable to revas-
cularization.5 Angiography consistently showed a diffuse
occlusive process involving the distal radial or ulnar arteries
and extending into the palmar and digital circulation. The
process was bilateral and symmetrical and had an angio-
graphic appearance consistent with atherosclerotic occlu-
sive disease. Not surprisingly, our patients with finger gan-
grene had significantly more clinical evidence for total body
atherosclerosis compared with those patients on chronic
hemodialysis in whom finger gangrene did not develop. It
is notable that 100% of our patients with finger gangrene
had clinical evidence for LED, with 70% needing major
lower extremity amputation compared with only 34% and
11%, respectively, in the comparison group (P  .05). In
addition, the patients with finger gangrene had significantly
higher prevalence rates of diabetes and CAD compared
with the other patients on chronic hemodialysis.
Our data suggest that the relatively young (55 years)
diabetic patient with ESRD with diffuse vascular disease is
at high risk for the eventual development of finger gan-
grene while on chronic hemodialysis. Although it was not
objectively assessed in our study, a number of our patients
with finger gangrene were known to have symptomatic
atherosclerotic disease at an age younger than 45 years.
Patients with premature atherosclerosis are reported to
have high mortality and amputation rates and decreased
vascular graft patency rates.6 The mean time on dialysis
before the development of finger gangrene was 36 months.
Although rate of survival on dialysis was no different for
Fig 2. Life table shows rate of freedom from repeat finger am-
putation.
Fig 3. Life table shows patient survival rate after onset of finger
gangrene.
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patients in whom finger gangrene developed compared
with other patients on chronic hemodialysis, the 2-year
survival rate once finger gangrene developed was only 27%.
Chronic hemodialysis appears to accelerate the athero-
sclerotic process, although little is objectively known about
the pathophysiology of this phenomenon. Patients on
chronic hemodialysis are well documented to have high
plasma homocysteine levels, and elevated plasma homocys-
teine levels have been associated with progression of vascu-
lar disease.7-9 Also, lipoprotein (a), another well known
atherosclerotic risk factor, is elevated in patients with
ESRD.6,10 In addition, an environment of increased oxi-
dant stress has been postulated in patients on chronic
hemodialysis, resulting in acceleration of the baseline ath-
erosclerotic process.11,12 Besides development of finger
gangrene, it is notable that 59% of our patients with LED
needed lower extremity revascularization while on chronic
hemodialysis. These data document progression of both
upper and lower extremity vascular disease in our hemodi-
alysis patient population.
Our series lacks data on hand blood supply in patients
at the onset of hemodialysis. In addition, our series is
somewhat atypical because it reflects the male-predominant
dialysis population that we serve. It appears, however, that
the young diabetic patient with ESRD and clinical evidence
for diffuse vascular disease is at significant risk for progres-
sive atherosclerosis and the development of finger gan-
grene. These patients should be counseled regarding their
risk and should undergo predialysis noninvasive testing to
include bilateral upper extremity pulse examination and
finger photoplethysmographic pressures. Upper extremity
fistulas or shunts, if used, should be thoughtfully planned,
and patients should have careful long-term longitudinal
follow-up and monitoring for the development of digital
ischemia, including finger photoplethysmographic pres-
sures with and without fistula compression.
Patients with ESRD with finger gangrene should un-
dergo angiography even though distal revascularization is
rarely possible. Angiography may identify significant prox-
imal arterial disease and document the extent of the distal
occlusive process. Also, patients with ipsilateral fistula can
undergo angiography with and without fistula compression
to assess for improvements in hand blood flow, which helps
select those patients who will benefit from fistula ligation
or, rarely, a DRIL procedure. Nonetheless, in most cases,
our clinical experience and angiographic findings indicate
that finger gangrene in patients with ESRD is primarily
related to severe distal atherosclerosis and not ischemic
steal syndrome.
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Variable (trait)
No. of all patients
(n  222)
with trait (%)
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finger gangrene
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Smoking history 205 (92) 185 (93) 20 (87) NS
Male gender 215 (97) 195 (98) 20 (87) NS
Diabetes 121 (55) 101 (51) 20 (87) .001
HTN 205 (92) 185 (93) 20 (87) NS
CAD 133 (60) 115 (58) 18 (78) .0212
LED 91 (41) 68 (34) 23 (100) .0001
HL 60 (27) 53 (27) 7 (30) NS
P value, from 2 analysis comparing patients with versus patients without trait in proportion of group having finger gangrene.
NS, Not significant; HTN, hypertension; HL, hyperlipidemia.
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DISCUSSION
Dr Spencer Galt (Salt Lake City, Utah). Dr Yeager and his
colleagues from Portland have brought to our attention an uncom-
mon but vexing clinical problem. In this paper, they have reviewed
their local experience in the evaluation and management of pa-
tients with end-stage renal disease presenting with finger gangrene.
They accurately point out that relatively little is known about the
etiology, natural history, prognosis, and management of this chal-
lenging group of patients.
This study identified 23 patients over a 10-year period with
finger gangrene on the combined vascular surgery services at the
Portland VA and University Hospital. Each of these patients was
undergoing chronic hemodialysis. Although we are not told the
denominator, this presumably represents a small minority of all
patients undergoing dialysis at the two hospitals.
I suspect that most of us would anticipate that the finger
gangrene was related, at least in part, to steal from an upper-
extremity fistula. However, we are told that fewer then half of these
patients initially presented with gangrene ipsilateral to the dialysis
fistula. Nevertheless, among the 10 patients in whom the gangrene
was ipsilateral to the fistula, one underwent a DRIL procedure, and
in three the fistula was ligated. In two additional patients, the
fistulae thrombosed, although presumably not as part of a manage-
ment plan. Therefore, in some of these patients, the managing
surgeon felt that steal was likely playing a role in the gangrene. This
brings me to my first question. While you mentioned that patients
underwent noninvasive testing, did that always include with and
without compression of the fistula? If so, was there any evidence of
increased hand perfusion with the fistula compressed? Further, do
you have any noninvasive data on hand perfusion in these patients
prior to the institution of dialysis?
Univariate analysis revealed that age of onset of dialysis 55
years, diabetes, the presence of CAD, and LEOD were significantly
associated with the development of finger gangrene. As you point
out in the discussion in the manuscript, chronic hemodialysis
appears to accelerate the atherosclerotic process. Nevertheless,
most patients on hemodialysis do not develop finger gangrene.
Would you please speculate for us what makes these patients more
susceptible to such severe and diffuse atherosclerosis?
The group from Portland has once again shed light on a
difficult clinical situation that most of us will encounter from time
to time. While the data suggest that there is little we can offer to
preserve fingers and prevent the progression of gangrene, these
patients fortunately remain free of major upper-extremity amputa-
tion during their short remaining life. I thank the Society for
inviting me to discuss this paper.
Dr James M. Edwards. Dr Galt, thank you for your com-
ments. In response to your questions I have the following com-
ments.
First, most of the upper-extremity vascular tests were done
with and without fistula compression, and there often was little
increase in finger pressure with the graft occluded. It is our
impression that this phenomenon is due to the severe and wide-
spread palmar and digital artery occlusive disease seen in these
patients. This finding reinforced our impression that the finger
gangrene seen in these patients was not due to a hemodynamic
steal from an arteriovenous fistula. We do not have data on what
the hand circulation in these patients was like prior to the institu-
tion of dialysis.
Your second question is more difficult to answer. I do not
know why some patients on dialysis develop finger gangrene. In my
experience there is a bimodal distribution with a few patients
developing finger ischemia early secondary to a hemodynamic steal
from an arteriovenous fistula, and then another group developing
finger ischemia late due to severe distal atherosclerosis, which is the
group we are describing. Our data demonstrate that this group is
younger, so perhaps they have an increased number of or more
severe comorbidities that lead to the early institution of dialysis and
that also lead to rapid and severe atherosclerosis.
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